Berlin-based femtech Inne raises €8 million to give natural contraception choice to women

Berlin-based femtech Inne raises €8 million to give natural contraception choice to women

Inne, the Berlin-based femtech, has raised an €8 million in Series A round, led by Blossom Capital with support Monkfish Equity, an early backer of the startup, as well as angel investors such as Taavet Hinrikus, co-founder of TransferWise; Tom Stafford, managing partner at DST; and Trivago co-founder Rolf Schromgens. The startup's mission is to help women make informed choices about their fertility, through a combination of technology and natural hormone tracking.

Founder and CEO Eirini Rapti started Inne in 2018 after working in healthcare for years and realizing, on a personal level, that natural fertility and contraception methods were hardly reliable in modern life.

“It’s hard to go a day without reading headlines about young women and their fertility. Women want to know more about their bodies and how to control their reproductive health. They may have concerns about when is the right time to start a family or they may already have decided that they don’t want to take hormones because of the side effects they experience. Many women feel that the current options do not meet their needs,” she explained.

Eirini wanted to develop technology that could assist women in understanding their bodies and contraceptive choices, and she knew the product had to satisfy the following requirements: compatible with a busy daily life, simple and hygienic to use, and more insightful than period-tracking apps already on the market.

The result is a saliva biosensor device that enables women to identify and predict the fertile phase in their natural cycle, and it has already achieved medical certification in Europe. Developed by a cross-functional team of scientists, designers and engineers who developed the biosensor and reader as well as the connected app, the Inne product will be available later this year.

Louise Samet, partner at Blossom Capital, said: “Inne has a winning combination of scientific validity plus usability that can enable women to better understand their bodies at all stages in their lives. What really impressed us is the team’s meticulous focus on design and easy-of-use together with the scientific validity and clear ambition to impact women all over the world. We are very excited to join Eirini and her extraordinary team on the next stage of their journey.”

The Series A will allow Inne to recruit across Europe and expand its team, specifically through engineering, design, and operations.

Follow the developments in the technology world. What would you like us to deliver to you?
Your subscription registration has been successfully created.